TrianecT logo — Getting stroke patients to the right hospital for the right...

TrianecT

Getting stroke patients to the right hospital for the right treatment as fast as possible.

Founded 2022 The Netherlands The Netherlands 6 employees Health Care, Medical Devices

General Information

Company Name TrianecT
Founded Year 2022
Location The Netherlands The Netherlands +1
Employees 6
Industries Health Care, Medical Devices
Social

Get notified when TrianecT moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About TrianecT

TrianecT is a startup with a mission to get stroke patients to the right hospital for the right treatment as fast as possible. With 10 million severe stroke patients picked up by ambulances annually, the company aims to address the issue of these patients being brought to hospitals that do not have endovascular treatment. This results in an average delay of endovascular treatment of 90 minutes, leading to worsened outcomes and a larger societal burden. The solution offered by TrianecT involves the combination of brain activity measurement and artificial intelligence to detect treatable stroke patients in the ambulance and bring them directly to their best treatment. By doing so, the company aims to save crucial time as it equates to saving brain function. Operating in the Health Care and Medical Devices industries, the startup was founded in 2022. However, specific details regarding headquarters, last investment, and investors are currently not available. The innovative approach of TrianecT to address the critical issue of stroke patient treatment presents an interesting opportunity for potential investors and stakeholders in the healthcare sector.

Taxonomy: Medical Technology, Stroke Treatment, Emergency Medical Services, Neurological Diagnostics, Healthcare Innovation, Brain Activity Measurement, Ambulance Technology, Endovascular Treatment, Emergency Response, Medical Device Development

No funding data available for TrianecT yet.

Get notified when TrianecT raises funding

TrianecT Alternatives & Competitors

TrianecT vs

Our medical device BraiN20 adresses the best management of Acute Ischemic Stroke | Neurology | Strok...

Pre Seed
15 employees
Health Care, Medical Devices
TrianecT vs

Building an AI neurologist to save the lives of stroke patients by providing better pre-CT diagnosti...

7 employees
TrianecT vs

Providing top-quality patient care through cutting-edge, minimally invasive treatment and procedures...

6 employees
Health Care, Health insurance

FAQ About TrianecT

Getting stroke patients to the right hospital for the right treatment as fast as possible.
TrianecT was founded in 2022.
TrianecT is headquartered in The Netherlands.
TrianecT operates in the following industries: Health Care, Medical Devices.
TrianecT has approximately 6 employees.
Top alternatives and competitors to TrianecT include Time is Brain, AI-Stroke, Elite Brain & Spine of Connecticut, Texas NeuroRehab Center, Acticor Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TrianecT and Time is Brain are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors TrianecT and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy